Supply of various pharmaceutical products

OSAKIDETZA - Servicio Vasco de Salud - Organización Central·Vitoria-Gasteiz, Spain·EUR 4.5M·Deadline Jul 06, 2026 · 12 days left·Open·Supplies

High valueStructured notice only

Original notice title

Suministro de Quetiapina (DOE), Heparina sódica (DOE), Inmunoglobulina antiD (RH) (DOE), Fentanilo (DOE) inyectable, Cafeína citrato (DOE), Nicotina (DOE) Parche transdérmico y Pazopanib (DOE)

60/100

Opportunity Score

Needs reviewMedium complexity

SuppliesOpen

Why this score?

Opportunity

60 / 100

Complexity

65 / 100

Risk factors

No procurement documents were analyzed; critical details such as contract terms, technical specifications, and specific...

Requires references on specific services and economic/financial standing; details not disclosed in the notice.

Submission deadline in 12 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

EUR 4.5M estimated value
Supplies contract
3 lots
Duration 1 YEAR
Supply of pharmaceutical products to the Basque Health Service (Osakidetza).
Products include: quetiapine, heparin sodium, anti-D immunoglobulin, fentanyl injectable, caffeine citrate, nicotine transdermal patches, and pazopanib.

Show full summary

Open tender by Osakidetza for the supply of various pharmaceutical products (quetiapine, heparin, immunoglobulins, fentanyl, caffeine citrate, nicotine patches, pazopanib) to the Basque Health Service. The contract is divided into 9 lots, each for a specific product. The estimated total value is €4,496,779.56. Submission deadline: 2026-07-06 10:00 UTC. Only the notice (TED XML) was analyzed; no procurement documents were extracted. Award is based on price (55%) and quality criteria (45%).

Risks

No procurement documents were analyzed; critical details such as contract terms, technical specifications, and specific...

Requires references on specific services and economic/financial standing; details not disclosed in the notice.

Submission deadline in 12 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

Tenderers may submit offers for one or more lots (maximum 9 lots).
Electronic submission required via the Basque procurement platform.
Tenders may be submitted in Spanish or Basque.

Requirements may be incomplete.

Award Criteria

Lot 1

Precio — 55%

Lot 2

Abastecimiento continuo del medicamento — 2%

Lot 3

Servicio al cliente y plazo de entrega de pedidos ordinarios — 2%

Lot 4

Mayor número de presentaciones disponibles en mercado — 1%

Lot 5

Eficiencia en el almacenaje — 3%

Lot 6

Acondicionamiento primario — 10%

Lot 7

Sistema que garantice la seguridad para el profesional en la manipulación del medicamento — 6%

Lot 8

Diferenciación visual de la dosis del medicamento — 4%

Lot 9

L5_FENTANILO (DOE) 0,05 mg/ml

SuppliesEU fundedElectronic submission

Location

ES211, Spain

Duration

1 YEAR

Category

Pharmaceutical products

Selection criteria

Cost

LOT-0006

6 - L6_CAFEÍNA CITRATO (DOE) 20 mg/ml

L6_CAFEÍNA CITRATO (DOE) 20 mg/ml

SuppliesEU fundedElectronic submission

Location

ES211, Spain

Duration

1 YEAR

Category

Pharmaceutical products

Selection criteria

Quality

LOT-0007

7 - L7_NICOTINA (DOE)

L7_NICOTINA (DOE)

SuppliesEU fundedElectronic submission

Location

ES211, Spain

Duration

1 YEAR

Category

Pharmaceutical products

Selection criteria

Quality

LOT-0008

8 - L8_HEPARINA SÓDICA (DOE) 1.000 UI/ML

L8_HEPARINA SÓDICA (DOE) 1.000 UI/ML

SuppliesEU fundedElectronic submission

Location

ES211, Spain

Duration

1 YEAR

Category

Pharmaceutical products

Selection criteria

Quality

LOT-0009

9 - L9_PAZOPANIB (DOE)

L9_PAZOPANIB (DOE)

SuppliesEU fundedElectronic submission

Location

ES211, Spain

Duration

1 YEAR

Category

Pharmaceutical products

Selection criteria

Quality

Procurement Details

Publication date: 03 Jun 2026
Notice type: Contract notice — standard
Languages: Spanish, Eus

Reference metadata

Notice subtype: 16
Notice version: 1
Legal basis: 32014L0024

Reference IDs

Tender ID: 382817-2026
Source notice ID: 51507690-4e08-4f8a-9d44-2c375d382609

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Denmark – Pharmaceutical products – Amgros 2027 1.1051.b

DNKAug 20

Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie

POLJul 27

Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE

ROUJul 21

Denmark – Pharmaceutical products – Amgros 2027 1.1052.b

DNKAug 20

Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem

LVAJul 20

Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml

ESPJul 21

60/100

Opportunity Score

Needs reviewMedium complexity

SuppliesOpen

Why this score?

Opportunity

60 / 100

Complexity

65 / 100

Risk factors

No procurement documents were analyzed; critical details such as contract terms, technical specifications, and specific...

Requires references on specific services and economic/financial standing; details not disclosed in the notice.

Submission deadline in 12 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications